Certified by Founder Lodge
MapLight Therapeutics, Inc.
United States - Palo Alto, CA
START UP
1 Disclosed Funding Rounds $225,000,000
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Maplight is a biopharmaceutical company discovering and developing novel therapeutics for patients with disorders of the central nervous system (CNS).
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| October, 31 ,2023 | Series C | $225,000,000 | |
| July, 29 ,2025 | Series D | $372,500,000.00 |
Novo Holdings
5AM Ventures
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Poetiq | $45,800,000 | (Feb 3, 2026)
1Buy.AI | $3,900,000 | (Feb 3, 2026)
Principle | $2,000,000 | (Feb 3, 2026)
Prenosis | $20,000,000 | (Feb 3, 2026)
PranaX | $17,000,000 | (Feb 3, 2026)
